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Introduction {#jdi12995-sec-0005}
============

Being obese or overweight is associated with the risk of developing type 2 diabetes, atherosclerosis, hyperlipidemia, steatosis and various cancers[1](#jdi12995-bib-0001){ref-type="ref"}, [2](#jdi12995-bib-0002){ref-type="ref"}, [3](#jdi12995-bib-0003){ref-type="ref"}. Adipocyte differentiation represents a multistep process involving a cascade of transcription factors for key proteins that induce gene expression and lead to adipocyte development. The 3T3‐L1 cell line is a well‐established preadipose cell line, which is useful for investigating the mechanisms underlying adipocyte proliferation, differentiation and lipid metabolism, as well as the identification of genes that regulate adipocyte physiology[4](#jdi12995-bib-0004){ref-type="ref"}, [5](#jdi12995-bib-0005){ref-type="ref"}.

Kelch repeat and BTB domain containing 11 (KBTBD11) belongs to the BTB superfamily, which includes the KLHL and KLHDC subfamilies, and has BTB/POZ and Kelch domains. The BTB/POZ domain functions as the domain for protein--protein interaction to enable dimer formation and an interaction with non‐BTB domain‐containing proteins, including the scaffold protein of the E3 ubiquitin ligase complex[6](#jdi12995-bib-0006){ref-type="ref"}, [7](#jdi12995-bib-0007){ref-type="ref"}. The Kelch domain, an evolutionarily conserved structure, widely found in mammals and insects, usually comprises two to seven repeats of four‐stranded β‐sheet motif forming one blade of the β‐propeller structure[7](#jdi12995-bib-0007){ref-type="ref"}, [8](#jdi12995-bib-0008){ref-type="ref"}.

A variant allele of *KBTBD11*, rs11777210, is significantly associated with colorectal cancer cell susceptibility. *KBTBD11* expression is significantly decreased in tumor tissues compared with that in adjacent paired normal tissues. Additionally, in colorectal cancer cells, *KBTBD11* knockdown inhibits apoptosis and promotes proliferation, whereas *KBTBD11* overexpression promotes apoptosis and inhibits cell growth. In tumorigenesis, *KBTBD11* is a putative tumor suppressor, the expression of which is regulated by MYC[9](#jdi12995-bib-0009){ref-type="ref"}.

*Kbtbd11* might play an important role in cellular differentiation and proliferation in tumor tissues. However, the expression profile and functional significance of *Kbtbd11* in adipose tissue is unknown. In the present study, we investigated the expression profile of *Kbtbd11* in adipose tissue and its effects in 3T3‐L1 preadipocyte differentiation.

Methods {#jdi12995-sec-0006}
=======

Animal Experiments {#jdi12995-sec-0007}
------------------

For all experiments, 8‐week‐old male C57BL/6J mice from Japan SLC (Hamamatsu, Japan) were used. The mice were maintained on a standard chow diet. For the fasting--refeeding protocol, the mice were subjected to fasting for 24 h and then fed a chow diet for 12 h. For obtaining diet‐induced obesity (DIO) mice, C57BL/6J mice were fed a high‐fat diet for 4 weeks. Feed ingredients content were as follows: the standard chow diet (CE*‐*2) comprised 50.3% carbohydrates, 25.4% protein and 4.4% fat. The high‐fat diet (HFD32) comprised 29.4% carbohydrates, 25.5% protein and 32.0% fat (CLEA Japan Inc., Tokyo, Japan). Animal experimental protocols were approved by the animal ethics committee of Jichi Medical University (permit number 17177), and were carried out in accordance with the Use and Care of Experimental Animals Guidelines of the Jichi Medical University Guide for Laboratory Animals.

Cells and Adipocyte Differentiation {#jdi12995-sec-0008}
-----------------------------------

3T3‐L1 cells were maintained in high‐glucose Dulbecco\'s modified Eagle\'s medium supplemented with 10% fetal bovine serum, and 100 units each of penicillin and streptomycin at 37°C in 5% CO~2~. For the adipocyte differentiation study, 3T3‐L1 cells were cultured to confluence. After 2 days, the medium was replaced with high‐glucose Dulbecco\'s modified Eagle\'s medium containing 5 μg/mL insulin, 1 μmol/L dexamethasone (DEX) and 0.5 mmol/L 3‐isobutyl‐1‐methylxanthine (IBMX). After 48 h, the medium was changed to high‐glucose Dulbecco\'s modified Eagle\'s medium containing 5 μg/mL insulin. The medium was renewed every other day.[10](#jdi12995-bib-0010){ref-type="ref"} For the adenovirus infection study, 3T3‐L1 cells at day 2 before the induction of differentiation were infected with adenovirus, and incubated for 0, 4 and 8 days.

Oil Red O Stain {#jdi12995-sec-0009}
---------------

3T3‐L1 cells were fixed with 10% formalin in phosphate‐buffered saline for 10 min at 37°C and stained with 60% Oil red O solution (Muto pure Chemicals Co., Tokyo, Japan) for 20 min at room temperature. The cells were washed with distilled water, and the retained dye was eluted by 60% isopropanol.

Adenoviral Expression Vectors {#jdi12995-sec-0010}
-----------------------------

Adenoviruses were prepared and amplified with the ViraPower Adenoviral Expression System (Invitrogen, Carlsbad, CA, USA), as previously described.[11](#jdi12995-bib-0011){ref-type="ref"} Polymerase chain reaction (PCR)‐amplified, mouse *Kbtbd11* complementary deoxyribonucleic acid was subcloned into the pENTR Directional TOPO vector (Invitrogen). The short hairpin ribonucleic acids (shRNAs) of *Kbtbd11* and *LacZ* were cloned into BLOCK‐iT U6 entry vector (Invitrogen). The sequence of the shRNA for *Kbtbd11* shRNA\#1 was as follows: 5′‐cacc GGACATATGTGAAATCTGA ttcaagaga TCAGATTTCACATATGTCC‐3′, and *Kbtbd11* shRNA\#2 was as follows: cacc GCAAGTAAGTGACATTTAA ttcaagaga TTAAATGTCACTTACTTGC. Inserts of pENTR vectors were transferred into the adenovirus vectors pAd/CMV‐DEST or pAd/PL‐DEST using the Gateway system (Invitrogen). Recombinant adenoviruses were purified by the Adenovirus Purification Miniprep Kit (Cell Biolabs, San Diego, CA, USA) according to the manufacturer\'s protocol.

Real‐Time PCR {#jdi12995-sec-0011}
-------------

Total RNA was isolated using acid guanidinium thiocyanate--phenol reagent.[12](#jdi12995-bib-0012){ref-type="ref"} Complementary deoxyribonucleic acid synthesis was carried out using the Verso cDNA Kit (Thermo Scientific, Waltham, MA, USA) with random hexamer primers. Quantitative PCR (qPCR) assays were carried out using the ViiA7 Real‐Time PCR System and KAPA SYBER FAST ROX Low qPCR kit (Kapa Biosystems, Wilmington, MA, USA).[12](#jdi12995-bib-0012){ref-type="ref"} Relative gene expression levels were quantified by qPCR followed by normalization to the internal control gene *36B4*. The following primers were used for this analysis: Kbtbd11 Fwd, 5′‐TCAGCGTTTTCCGCTACCAT‐3′ and Kbtbd11 Rv, 5′‐AACACAACGAAAGGGCTGGA‐3′; Cebpa Fwd, 5′‐GCCATGCCGGGAGAACTCTA‐3′ and Cebpa Rv, 5′‐ GGGCTCTGGAGGTGACTGCT‐3′; Cebpb Fwd, 5′‐GAGCCGCGACAAGGCCAAGA‐3′ and Cebpb Rv, 5′‐GCTCGTTCTCCGCCGTCAGC‐3′; Pparg Fwd, 5′‐ TTCCACTATGGAGTTCATGCTTGT‐3′ and Pparg Rv, 5′‐ TCCGGCAGTTAAGATCACACCTA‐3′; p27 Fwd, 5′‐AGGAGAGCCAGGATGTCAGC‐3′ and p27 Rv, 5′‐ CAGAGTTTGCCTGAGACCCAA‐3′; Cyclin D1 Fwd, 5′‐GTTCATTTCCAACCCACCCTC‐3′ and Cyclin D1 Rv, 5′‐AGAAAGTGCGTTGTGCGGTAG‐3′; Bax Fwd, 5′‐GCTGACATGTTTGCTGATGG‐3′ and Bax Rv, 5′‐ GATCAGCTCGGGCACTTTAG‐3′; Bcl2 Fwd, 5′‐CTGGGATGCCTTTGTGGAAC‐3′ and Bcl2 Rv, 5′‐GAGACAGCCAGGAGAAATCAAAC‐3′; Tnfa Fwd, 5′‐CAGCCGATGGGTTGTACCTT‐3′ and Tnfa Rv, 5′‐ GGGCTCATACCAGGGTTTGA‐3′; Il6 Fwd, 5′‐GAGGATACCACTCCCAACAGACC‐3′ and Il6 Rv, 5′‐ AAGTGCATCATCGTTGTTCATACA‐3′; 36B4 Fwd, 5′‐ATGCAGCAGATCCGCATGT‐3′ and 36B4 Rv, 5′‐TTGCGCATCATGGTGTTCTT‐3′.

Statistical Analysis {#jdi12995-sec-0012}
--------------------

Experimental studies were carried out in triplicates or greater. Statistical significance was tested using the unpaired two‐tailed Student\'s *t*‐test. Data are shown as mean ± standard error of the mean. Differences were considered to be significant at *P* \< 0.05.

Results {#jdi12995-sec-0013}
=======

*Kbtbd11* mRNA Expression in Epididymal White Adipose Tissue {#jdi12995-sec-0014}
------------------------------------------------------------

We first examined the expression pattern of *Kbtbd11* in epididymal white adipose tissue (eWAT) of C57BL/6J mice in the fasted and re‐fed states. In the fasted state, *Kbtbd11* mRNA expression was low, but was profoundly promoted by re‐feeding in the eWAT of C57BL/6J mice (Figure [1](#jdi12995-fig-0001){ref-type="fig"}a). Next, we compared the expression of *Kbtbd11* levels in the eWAT of obese mice. In DIO mice, *Kbtbd11* mRNA was elevated \>10‐fold (Figure [1](#jdi12995-fig-0001){ref-type="fig"}b). These results show that *Kbtbd11* expression levels might be dependent on triglyceride accumulation in WAT.

![*Kbtbd11* expression levels in epididymal white adipose tissue. (a) The expression of *Kbtbd11* in epididymal white adipose tissue of C57BL/6J mice; mice were fasted for 24 h or fasted for 24 h/re‐fed for 12 h; *n* = 3 per group, \**P* \< 0.01 versus fasted. (b) The expression of *Kbtbd11* in epididymal white adipose tissue of diet‐induced obesity mice; diet‐induced obesity mice were fed a high‐fat diet for 1 month. The mice were fasted for 24 h; *n* = 3 per group, \**P* \< 0.01 versus chow.](JDI-10-925-g001){#jdi12995-fig-0001}

*Kbtbd11* Expression During 3T3‐L1 Adipose Differentiation {#jdi12995-sec-0015}
----------------------------------------------------------

To elucidate whether *Kbtbd11* plays a role in adipose differentiation, we examined the expression of *Kbtbd11* in 3T3‐L1 cell differentiation using qPCR methods. 3T3‐L1 cells were induced to differentiate using a cocktail mix that included DEX, IBMX and insulin. RNA was extracted from cells at day 0, 2, 4, 8 and 10 after the induction of adipocyte differentiation. *Kbtbd11* expression increased by fourfold between day 0 and day 4. Furthermore, during 3T3‐L1 cell differentiation, *Kbtbd11* levels subsequently increased by 18‐fold compared with those on day 0 (Figure [2](#jdi12995-fig-0002){ref-type="fig"}). Figure [2](#jdi12995-fig-0002){ref-type="fig"} shows the expression levels of CCAAT/enhancer‐binding protein alpha (*Cebpa*) and peroxisome proliferator‐activated receptor gamma (*Pparg*), which are the transcription factors of adipogenic differentiation induced during adipose differentiation. *Cebpb*, the key early regulator of adipogenesis, was also induced. These results suggested that an increase in *Kbtbd11* mRNA expression might be related to lipid accumulation and adipose differentiation.

![*Kbtbd11* messenger ribonucleic acid (mRNA) expression in differentiating 3T3‐L1 cells. Total RNA was extracted from 3T3‐L1 cells at day 0, 2, 4, 8 and 10 after the induction of differentiation by treatment with an adipogenic cocktail; *n* = 3 per group, \**P* \< 0.01 versus day 0.](JDI-10-925-g002){#jdi12995-fig-0002}

Expression of *Kbtbd11* During Early 3T3‐L1 Adipose Differentiation {#jdi12995-sec-0016}
-------------------------------------------------------------------

3T3‐L1 cells undergo differentiation to adipocytes in response to a cocktail of adipogenic stimuli containing insulin; the synthetic glucocorticoid, DEX; and the phosphodiesterase inhibitor, IBMX.[13](#jdi12995-bib-0013){ref-type="ref"} As *Kbtbd11* mRNA expression increased in the re‐fed eWAT and during 3T3‐L1 adipose differentiation, the presence of individual adipogenic stimuli in the short‐term might have any influence on *Kbtbd11* mRNA expression in 3T3‐L1 preadipocytes. To elucidate the *Kbtbd11* expression pattern in individual adipogenic factors, 3T3‐L1 preadipocytes were collected at 0, 1, 4 and 8 h after the addition of one of the following: insulin, DEX and IBMX. Total RNA was then isolated from cells and subjected to qPCR to evaluate *Kbtbd11* mRNA levels. *Kbtbd11* mRNA levels increased rapidly by insulin, and were upregulated threefold at early times from 2 to 4 h after the addition of DEX (Figure [3](#jdi12995-fig-0003){ref-type="fig"}a,b). After the addition of IBMX, *Kbtbd11* mRNA gradually, but significantly, increased from 4 h to 8 h. The levels of *Cebpa* and *Cebpb*, the inducers of adipocyte differentiation, also rapidly increased in preadipocytes by adding individual drugs. These results suggested that *Kbtbd11* transcripts, increased rapidly by the adipogenic cocktail, were involved in 3T3‐L1 adipocyte differentiation.

![*Kbtbd11* messenger ribonucleic acid (mRNA) expression in response to adipogenic stimuli at early time points. 3T3‐L1 preadipocytes were cultured to confluence, serum‐starved for 12 h and treated with (a) 5 μg/mL insulin, (b) 2.5 μmol/L dexamethasone (DEX) or (c) 200 μmol/L 3‐isobutyl‐1‐methylxanthine (IBMX) for the indicated times; *n* = 3 per group, \**P* \< 0.01 versus 0 h.](JDI-10-925-g003){#jdi12995-fig-0003}

Knockdown and overexpression of *Kbtbd11* mRNA are reciprocally involved in mitotic clonal expansion (MCE) and triglyceride accumulation during 3T3‐L1 adipocyte differentiation {#jdi12995-sec-0017}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To investigate the role of *Kbtbd11* in adipocyte differentiation, including in the early stage, we examined the effects of *Kbtbd11* knockdown on 3T3‐L1 differentiation. Adenoviral infection of either of the two independent *Kbtbd11* shRNA constructs decreased *Kbtbd11* mRNA expression levels by up to approximately 60% compared with that of the LacZ‐specific short hairpin ribonucleic acid (shLacZ) control (Figure [4](#jdi12995-fig-0004){ref-type="fig"}a). On day 8, after inducing differentiation, the shLacZ control cells showed abundant lipid droplets (observed with Oil Red O staining) (Figure [4](#jdi12995-fig-0004){ref-type="fig"}b), and a significant increase in the expression of *Cebpa*,*Cebpb* and *Pparg* during the middle (day 4) and late stages (day 8) of 3T3‐L1 adipogenesis. In addition, in the early stage, the mRNA expression of *Cebpb* was upregulated, reaching a peak at 2 h after the induction of differentiation. Furthermore, the expression of *Cyclin D1*, acting on MCE, rapidly increased in preadipocytes after the addition of the adipogenic cocktail. Meanwhile, the expression of *p2*7, a key regulator of cell cycle progression, decreased (Figure [4](#jdi12995-fig-0004){ref-type="fig"}c). In contrast, lipid accumulation and adipocyte differentiation markers (*Cebpa*,*Cebpb* and *Pparg*) were significantly decreased in *Kbtbd11*‐knockdown cells during the middle and late stages of 3T3‐L1 adipogenesis (Figure [4](#jdi12995-fig-0004){ref-type="fig"}b,c). In the early stage, *Cebpb* and *Cyclin D1* were significantly decreased and *p27* was increased in *Kbtbd11*‐knockdown cells (Figure [4](#jdi12995-fig-0004){ref-type="fig"}c). In *Kbtbd11*‐overexpressing 3T3‐L1 cells, *Kbtbd11* mRNA expression increased by 40‐fold (Figure [4](#jdi12995-fig-0004){ref-type="fig"}d), which promoted lipid accumulation (Figure [4](#jdi12995-fig-0004){ref-type="fig"}e). Adipocyte differentiation markers were significantly increased in the *Kbtbd11*‐overexpressing 3T3‐L1 cells on days 4 and 8 after the induction of differentiation. In the early stage, *Cebpb* and *Cyclin D1* were significantly increased, and *p27* was decreased in *Kbtbd11*‐overexpressing cells (Figure [4](#jdi12995-fig-0004){ref-type="fig"}f). These results suggest that *Kbtbd11* plays an important role in MCE, and is involved in triglyceride accumulation and adipocyte differentiation.

![The effects of knockdown and overexpression of *Kbtbd11* on 3T3‐L1 cellular differentiation. (a) The expression of *Kbtbd11* messenger ribonucleic acid (mRNA) in *Kbtbd11* knockdown 3T3‐L1 cells at day 8. *Kbtbd11* knockdown adenovirus particles were used with either of the two independent *Kbtbd11* short hairpin ribonucleic acid (shRNA) constructs (shRNA\#1 and shRNA\#2); *n* = 3 per group, \**P* \< 0.01 versus LacZ‐specific short hairpin ribonucleic acid (shLacZ); (b) triglyceride accumulation in 3T3‐L1 cells on day 8, visualized using Oil Red O staining; (c) the mRNA levels in 3T3‐L1 cells expressing each shRNA at various time points after inducing differentiation; *n* = 3 per group, \**P* \< 0.01 versus shLacZ; (d) the expression of *Kbtbd11* mRNA in *Kbtbd11*‐overexpressing 3T3‐L1 cells at day 8. Cells were infected with adenoviral vectors for expressing green fluorescent protein (GFP) or mouse *Kbtbd11*;*n* = 3 per group, \**P* \< 0.01 versus GFP; (e) triglyceride accumulation in 3T3‐L1 cells on day 6 was detected using Oil Red O staining. (f) Relative mRNA levels in each group of 3T3‐L1 cells at various time points after inducing differentiation; *n* = 3 per group, \**P* \< 0.01 versus GFP.](JDI-10-925-g004){#jdi12995-fig-0004}

Effects of *Kbtbd11* Knockdown on Mature 3T3‐L1 Adipocytes {#jdi12995-sec-0018}
----------------------------------------------------------

To examine the role of *Kbtbd11* in mature adipocytes, we investigated effects of *Kbtbd11* knockdown on mature 3T3‐L1 adipocytes. On day 8 after the induction of differentiation, mature 3T3‐L1 adipocytes were infected with adenoviral vectors for expressing shLacZ control or *Kbtbd11* shRNA. *Kbtbd11* adenoviral shRNA decreased *Kbtbd11* mRNA expression levels by up to approximately 60% compared with the shLacZ control (Figure [5](#jdi12995-fig-0005){ref-type="fig"}b). The number of lipid droplets of mature 3T3‐L1 adipocytes was not different between the shLacZ control and *Kbtbd11* knockdown (Figure [5](#jdi12995-fig-0005){ref-type="fig"}a). mRNA expression analyses of adipocytes (*Pparg* and *aP2*) and inflammation markers (*Tnfa* and *Il6*), as well as lipogenic (*Fasn*) and proapoptotic genes (*Bax* and *Bcl2*), were carried out using qPCR. mRNA levels of these markers and genes in adipocytes were not different compared with those in shLacZ control, suggesting that *Kbtbd11* might only play a role in the early stage of adipogenesis.

![Effects of knockdown of *Kbtbd11* on mature 3T3‐L1 adipocytes. (a) Triglyceride accumulation in *Kbtbd11*‐knockdown mature 3T3‐L1 adipocytes at 48 h after either of the two independent *Kbtbd11* short hairpin ribonucleic acid (shRNA) adenoviral infections (shRNA\#1 and shRNA\#2) visualized using Oil Red O staining; (b) RNA was harvested at 48 h after adenoviral infection, and expression levels of *Kbtbd11*, adipocytes (*Pparg* and *aP2*) and inflammation markers (*Tnfa* and *Il6*), and lipogenic (*Fasn*) and proapoptotic genes (*Bax* and *Bcl2*) were measured using quantitative polymerase chain reaction; *n *=* *3 per group, \**P* \< 0.01 versus shLacZ.](JDI-10-925-g005){#jdi12995-fig-0005}

Discussion {#jdi12995-sec-0019}
==========

In the present study, we identified *Kbtbd11* as a newly discovered adipogenesis‐related gene. At first, we examined the expression of *Kbtbd11* mRNA in nutritional regulation and obese adipose tissue using qPCR analysis. *Kbtbd11* was significantly increased in re‐fed eWAT compared with that in fasted eWAT, and was strongly induced in eWAT of DIO mice compared with that in the mice fed a chow diet (Figure [1](#jdi12995-fig-0001){ref-type="fig"}b). We hypothesized that the elevation of *Kbtbd11* in eWAT of obese mice might be associated with the accumulation of triglyceride in adipocytes. Next, we investigated whether *Kbtbd11* was induced in 3T3‐L1 cells during adipose differentiation. The present results showed that *Kbtbd11* expression was induced during 3T3‐L1 adipocyte differentiation (Figure [2](#jdi12995-fig-0002){ref-type="fig"}). These findings, demonstrating that *Kbtbd11* mRNA expression levels in 3T3‐L1 adipocytes show differentiation‐dependent expression, support our hypothesis.

As *Kbtbd11* mRNA expression increased in the re‐fed eWAT, and during 3T3‐L1 adipose differentiation, we further examined whether *Kbtbd11* transcription is regulated by insulin, DEX and IBMX individually. The present results showed that the expression of *Kbtbd11* was rapidly increased by insulin (Figure [3](#jdi12995-fig-0003){ref-type="fig"}a), suggesting that *Kbtbd11* is indeed regulated by nutritional regulation. The differentiation of 3T3‐L1 preadipocytes into adipocytes was accompanied by a transient induction of *Cebpb* expression in response to treatment with IBMX and DEX, respectively. In addition, C*ebpb* led to the upregulation of the expression of adipogenic factors, such as *Cebpa* and *Pparg*, which appears to perform an important function in adipogenesis by controlling the late‐stage differentiated phenotype.[14](#jdi12995-bib-0014){ref-type="ref"} After the addition of DEX and IBMX, respectively, in 3T3‐L1 preadipocytes, *Kbtbd11* was upregulated later than the expression of *Cebpa* and *Cebpb* (Figure [3](#jdi12995-fig-0003){ref-type="fig"}b,c). These data suggested that *Kbtbd11* is regulated by adipogenic factors and related to adipose differentiation process.

Additional convincing evidence came from our results showing a close relationship between *Kbtbd11* and adipocyte differentiation in 3T3‐L1 cells. In *Kbtbd11* knockdown cells, differentiation of 3T3‐L1 adipocytes was markedly inhibited, with an accompanying decrease in the expression of *Cebpa* and *Pparg* (Figure [4](#jdi12995-fig-0004){ref-type="fig"}b,c). Conversely, *Kbtbd11*‐overexpressing 3T3‐L1 cells upregulated the expression of *Cebpa*,*Cebpb* and *Pparg*. Together, these results suggested that *Kbtbd11* regulates the differentiation of 3T3‐L1 adipocytes.

After hormonal induction, growth‐arrested 3T3‐L1 preadipocytes synchronously re‐enter the cell cycle for one to two rounds of cell division, a phenomenon known as MCE, which is one of the important events occurring at the early stage during 3T3‐L1 adipocyte differentiation. Cyclin D1 functions as a key sensor for mitogenic stimuli and promotes cell cycle progression from the G1 to S phase.[15](#jdi12995-bib-0015){ref-type="ref"} In contrast, p27, a cyclin‐dependent kinase inhibitor, is a key negative regulator of the cell cycle during progression from the G1 to S phase.[16](#jdi12995-bib-0016){ref-type="ref"} The balance of the cyclin D1‐p27 control system might play an important role in MCE. After MCE, CEBPB activates *Cebpa* and *Pparg*, which then transcriptionally activate genes that give rise to the adipocyte phenotype. These are accompanied by the early events of the cell cycle and initiation of a transcriptional cascade, which results in terminal adipogenic differentiation.[17](#jdi12995-bib-0017){ref-type="ref"} Because *KBTBD11* is associated with cellular differentiation and proliferation in tumor tissues,[9](#jdi12995-bib-0009){ref-type="ref"} *Kbtbd11* might play an important role in MCE of 3T3‐L1 differentiating adipocytes. Although *KBTBD11* knockdown promotes proliferation in colorectal cancer cells, *Kbtbd11* knockdown inhibits MCE and 3T3‐L1 differentiating adipocytes. The role of *Kbtbd11* in 3T3‐L1 adipogenesis might be different from that in cellular differentiation and proliferation during tumorigenesis. Furthermore, *Kbtbd11* knockdown inhibited adipogenesis, but only before MCE (not mature 3T3‐L1 adipocytes), and *Kbtbd11* overexpression induced MCE, leading to the expression of *Cebpa* and *Pparg* (Figure [4](#jdi12995-fig-0004){ref-type="fig"}c,f).

In conclusion, the present study shows that *Kbtbd11* expression is involved in nutritional regulation and is increased in obese adipose tissue. *Kbtbd11* is a regulator of 3T3‐L1 adipose differentiation that acts in the early stages of adipogenesis. These data showed a novel link between the expression of *Kbtbd11* and fat accumulation, suggesting that *Kbtbd11* could represent a new therapeutic target in obesity. However, further research is required to elucidate the physiological functions of *Kbtbd11*. KBTBD11 transgenic mice have not yet been reported, but would be an important biological tool in understanding the molecular mechanism(s) of adipogenesis, including adipocyte differentiation.

Disclosure {#jdi12995-sec-0021}
==========

The authors declare no conflict of interest.

This study was supported by grants‐in‐aid (15K19523, 17K16153 and 17K09864) from Japan Society for the Promotion of Science (JSPS); a MEXT‐supported program for the strategic research foundation at private universities (2013--2017); and Jichi Medical University young investigator award. Ms Kayo Nagashima and Ms Yukiko Ohashi for their excellent technical assistance.
